ArticlesDownstream December 2, 2024 Cleaning ÄKTA process™ CFG system: Part 1 CytivaStaphylococcus aureus (S. aureus) is an organism that can be problematic to eradicate, particularly for… Jeanne Linke
ArticlesDownstreamUpstream November 15, 2024 Production of a highly concentrated monoclonal antibody CytivaDemonstrating an end to end mAb process with final concentration over 200 g/L Subcutaneous (SC)… Jeanne Linke
ArticlesDownstreamDownstreamEventsUpstreamUpstream November 15, 2024 From bottlenecks to breakthroughs: mastering buffer management CytivaTraditional process liquid and buffer manufacturing has been shown to be resource-intensive, in both facility… Jeanne Linke
ArticlesDownstreamDownstreamMultimediaUpstreamUpstream November 15, 2024 An expert’s guide to scaling and intensifying bioprocesses CytivaRequest the eBook Knowing you need to improve your bioprocess is one thing; deciding how… Jeanne Linke
ArticlesDownstreamDownstreamEventsUpstreamUpstream November 15, 2024 ÄKTA readyflux™ virtual demonstration on December 4, 2024 CytivaWhat features make a filtration system especially useful for pilot- and small-scale manufacturing? How much… Jeanne Linke
ArticlesDownstreamDownstreamEvents November 1, 2024 On-demand webinar: In silico process development for AAVs – Learn from MeiraGTx CytivaThe biotherapeutics pipeline is evolving and so are the tools to purify and manufacture therapeutic… Jeanne Linke